基本信息
浏览量:11
职业迁徙
个人简介
Libby Roughead's research focuses on quantifying the extent of problems with medicines use, identifying the extent of adverse reactions to medicines, testing solutions for improving medicines use and evaluating improvements in health care.
Her research supports pharmaceutical policy development, she has expertise in developing and measuring performance indicators for evaluating pharmaceutical policy, including the development and measurement of performance indicators for quality use of medicines and the national medicines policy
She has extensive experience in drug utilisation and has been a member of Australia’s Drug Utilisation Subcommittee of the Pharmaceutical Benefits Advisory Committee providing advice on drug utilisation assessment for Australia. Libby has also acted as a temporary advisor to the World Health Organisation at regional meetings on medicines policy, pricing and quality use of medicines.
Libby leads the:
Veterans' Medicines Advice and Therapeutics Education Services (MATES) program. This ongoing program has delivered over 65 therapeutic topics and targeted every general practioner, pharmacy, aged-care facility and veteran in Australia. The program has led to improvements in medicine use and reductions in hospitalisations.
Reducing Medicines Induced Deterioration and Adverse Reactions (ReMInDAR) Trial, aimed at enabling the early identification of signs and symptons of medicine induced deterioration in residental aged care residents to minimise the ongoing deterioration and adverse events such as falls and delirium.
She currently supervises PhD students undertaking research in the area of medicine use and frailty, harm from medicine interactions, the pharmacists role in delirium prevention, managed entry agreements for pharmaceuticals, fixed dose combination products and policy implications, and signal detection methods for medicine and medical device safety.
Her research supports pharmaceutical policy development, she has expertise in developing and measuring performance indicators for evaluating pharmaceutical policy, including the development and measurement of performance indicators for quality use of medicines and the national medicines policy
She has extensive experience in drug utilisation and has been a member of Australia’s Drug Utilisation Subcommittee of the Pharmaceutical Benefits Advisory Committee providing advice on drug utilisation assessment for Australia. Libby has also acted as a temporary advisor to the World Health Organisation at regional meetings on medicines policy, pricing and quality use of medicines.
Libby leads the:
Veterans' Medicines Advice and Therapeutics Education Services (MATES) program. This ongoing program has delivered over 65 therapeutic topics and targeted every general practioner, pharmacy, aged-care facility and veteran in Australia. The program has led to improvements in medicine use and reductions in hospitalisations.
Reducing Medicines Induced Deterioration and Adverse Reactions (ReMInDAR) Trial, aimed at enabling the early identification of signs and symptons of medicine induced deterioration in residental aged care residents to minimise the ongoing deterioration and adverse events such as falls and delirium.
She currently supervises PhD students undertaking research in the area of medicine use and frailty, harm from medicine interactions, the pharmacists role in delirium prevention, managed entry agreements for pharmaceuticals, fixed dose combination products and policy implications, and signal detection methods for medicine and medical device safety.
研究兴趣
论文共 428 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Drug Utilization Researchpp.557-562, (2024)
Studies in health technology and informatics (2024)
Eyob Alemayehu Gebreyohannes,Christopher Thornton,Myra Thiessen, Sieta T de Vries,Andre Andrade,Lisa Kalisch Ellett,Oliver Frank,Phaik Yeong Cheah,Kim-Kwang Raymond Choo,Tracey Lea Laba,Elizabeth E Roughead, Indae Hwang, Geraldine Moses,Renly Lim
JMIR Research Protocols (2024)
BMC HEALTH SERVICES RESEARCHno. 1 (2024)
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGYno. 10 (2024): 1543-1554
Twisha R. Banker,Marianne H. Gillam,Peter O'Loughlin,Wayne Rankin,Richard Ryan, Connie Caruso,Elizabeth E. Roughead
AMERICAN JOURNAL OF CLINICAL PATHOLOGYno. 4 (2024): 342-348
BMJ OPENno. 2 (2024)
N. Kumsa,M. Gillam,R. Tavella, J. Wu, T. Kelly,E. Roughead,A. Sinhal,M. Arstall, M. Worthley, C. Zeitz,J. Beltrame
Heart, Lung and Circulation (2024): S507
BMJ quality & safetyno. 11 (2023): 623-631
加载更多
作者统计
#Papers: 430
#Citation: 10467
H-Index: 49
G-Index: 88
Sociability: 7
Diversity: 4
Activity: 172
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn